Lonza | LONN - Assets


Lonza reported CHF18.97B in Assets for its fiscal semester ending in December of 2025.





Assets Change Date
Akzo Nobel EUR 16.13B 647M Jun/2026
Alcon AG USD 31.62B 64M Mar/2026
Almirall EUR 2.37B 29.97M Jun/2026
AstraZeneca USD 115.83B 1.82B Jun/2026
BASF EUR 83.87B 2.1B Jun/2026
Bayer EUR 107.94B 3.4B Mar/2026
Beiersdorf EUR 12.76B 166M Dec/2025
Covestro EUR 13.47B 245M Dec/2025
Demant DKK 39.07B 6.43B Dec/2025
Fresenius EUR 41.84B 526M Jun/2026
Fresenius Medical Care EUR 31.47B 465.26M Mar/2026
Geberit CHF 3.86B 252.6M Dec/2025
Genmab DKK 12.38B 497M Mar/2026
Givaudan CHF 11.86B 587M Dec/2025
GlaxoSmithKline GBP 61.74B 1.13B Jun/2026
GN Store Nord DKK 28.56B 671M Mar/2026
Hikma Pharmaceutical USD 5.67B 117M Dec/2025
Johnson Matthey GBP 5.97B 142M Jun/2026
Merck EUR 53.07B 1.54B Mar/2026
Novartis USD 122.03B 3.5B Jun/2026
Philips EUR 26.7B 565M Jun/2026
Roche Holding CHF 98.2B 2.5B Jun/2026
Sanofi EUR 129.06B 1.04B Jun/2026
Sika AG CHF 15.15B 245M Dec/2025
Smith & Nephew USD 11.01B 321M Jun/2026
Solvay EUR 6.08B 122M Jun/2026
UCB EUR 18.16B 971M Dec/2025